Richard Baird
Overview
Explore the profile of Richard Baird including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
1857
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zareian N, Eremin O, Pandha H, Baird R, Kwatra V, Funingana G, et al.
Exp Biol Med (Maywood)
. 2024 Mar;
249:10021.
PMID: 38463391
The presence of inhibitory immune cells and difficulty in generating activated effector T cells remain obstacles to development of effective cancer vaccines. We designed a vaccine regimen combining human telomerase...
2.
Ortiz V, Chang H, Sang H, Jacobs J, Malvick D, Baird R, et al.
Front Genet
. 2023 Jun;
14:1103969.
PMID: 37351341
causes charcoal rot, which can significantly reduce yield and seed quality of soybean and dry bean resulting from primarily environmental stressors. Although charcoal rot has been recognized as a warm...
3.
Jaki T, Burdon A, Chen X, Mozgunov P, Zheng H, Baird R
Eur J Cancer
. 2023 Jun;
189:112916.
PMID: 37301716
Background: The pharmaceutical industry's productivity has been declining over the last two decades and high attrition rates and reduced regulatory approvals are being seen. The development of oncology drugs is...
4.
Cani A, Dolce E, Darga E, Hu K, Liu C, Pierce J, et al.
Mol Oncol
. 2021 Dec;
16(10):1969-1985.
PMID: 34866317
Nearly all estrogen receptor (ER)-positive (POS) metastatic breast cancers become refractory to endocrine (ET) and other therapies, leading to lethal disease presumably due to evolving genomic alterations. Timely monitoring of...
5.
Woitek R, McLean M, Gill A, Grist J, Provenzano E, Patterson A, et al.
Radiol Imaging Cancer
. 2020 Aug;
2(4):e200017.
PMID: 32803167
Purpose: To compare hyperpolarized carbon 13 (C) MRI with dynamic contrast material-enhanced (DCE) MRI in the detection of early treatment response in breast cancer. Materials And Methods: In this institutional...
6.
Tamborero D, Dienstmann R, Rachid M, Boekel J, Baird R, Brana I, et al.
Nat Med
. 2020 Jul;
26(7):992-994.
PMID: 32632195
No abstract available.
7.
Gallagher F, Woitek R, McLean M, Gill A, Manzano Garcia R, Provenzano E, et al.
Proc Natl Acad Sci U S A
. 2020 Jan;
117(4):2092-2098.
PMID: 31964840
Our purpose is to investigate the feasibility of imaging tumor metabolism in breast cancer patients using C magnetic resonance spectroscopic imaging (MRSI) of hyperpolarized C label exchange between injected [1-C]pyruvate...
8.
Reazin C, Baird R, Clark S, Jumpponen A
Mycorrhiza
. 2019 May;
29(4):313-324.
PMID: 31129728
Restoration of the American chestnut (Castanea dentata) is underway using backcross breeding that confers chestnut blight disease resistance from Asian chestnuts (most often Castanea mollissima) to the susceptible host. Successful...
9.
Gao M, Callari M, Beddowes E, Sammut S, Grzelak M, Biggs H, et al.
Genome Med
. 2019 Jan;
11(1):1.
PMID: 30609936
Circulating tumour DNA (ctDNA) detection and monitoring have enormous potential clinical utility in oncology. We describe here a fast, flexible and cost-effective method to profile multiple genes simultaneously in low...
10.
Paoletti C, Schiavon G, Dolce E, Darga E, Carr T, Geradts J, et al.
Clin Cancer Res
. 2018 Aug;
24(23):5860-5872.
PMID: 30082476
Purpose: Common resistance mechanisms to endocrine therapy (ET) in estrogen receptor (ER)-positive metastatic breast cancers include, among others, ER loss and acquired activating mutations in the ligand-binding domain of the...